cGAS-STING signaling in cancer immunity and immunotherapy

Area of Science:

• Immunology
• Oncology
• Molecular Biology

Background:

• The innate immune cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) pathway is increasingly recognized for its role in antitumor immunity.
• This pathway influences cancer cell fate by inducing senescence and apoptosis.
• It also enhances the efficacy of cytotoxic T cells and natural killer cells against tumors.

Purpose of the Study:

• To review the antitumor mechanisms of the cGAS-STING signaling pathway.
• To highlight recent advances in monotherapy and combination therapy utilizing cGAS-STING agonists.
• To explore the potential of cGAS-STING pathway modulation for overcoming therapeutic obstacles in cancer treatment.

Main Methods:

• Literature review of studies investigating the cGAS-STING pathway in cancer.
• Analysis of research on cGAS-STING agonists in monotherapy and combination therapy settings.
• Synthesis of findings on the immunomodulatory effects of cGAS-STING activation in cancer.

Main Results:

• The cGAS-STING pathway exhibits significant antitumor effects, including promoting cancer cell senescence and apoptosis.
• Activation of the cGAS-STING pathway augments cytotoxic T cell and natural killer cell-mediated antitumor responses.
• Emerging evidence supports the therapeutic potential of cGAS-STING agonists in various cancer models.

Conclusions:

• The cGAS-STING pathway is a critical component of the innate immune response against cancer.
• Modulating the cGAS-STING pathway, particularly through agonists, offers a promising strategy for cancer immunotherapy.
• Combination therapies involving cGAS-STING agonists represent a novel approach to enhance treatment efficacy and overcome resistance.